No abstract

Groundnut (Arachis hypogaea L.) is a major oilseed crop of India. Groundnut has great potential for diversification, from oil extraction to food uses, due to its high nutritive value. Aflatoxin contamination is the major impediment to such diversification. Aflatoxins, produced by the fungi Aspergillus flavus and A. parasiticus, are the major toxins affecting the quality of groundnut meant for human consumption. The adoption of 'Aflatoxin Management Practices of Groundnut' (AMPG) is very important for reducing aflatoxin contamination. This study was undertaken with the aims of determining the extent of adoption of AMPG by farmers, to assess the constraints upon adoption of AMPG and to understand the relationship between adoption of AMPG by farmers and socio-economic and psychological factors. The results indicated that the majority of the farmers were unaware of aflatoxin contamination and hence had not adopted sowing, post-sowing and post-harvest aflatoxin management practices. The farmers with large land holdings were high adopters of AMPG compared to farmers with small land holdings. Socio-economic and psychological characteristics such as innovativeness, perception of groundnut quality, extension participation, socioeconomic status, market orientation and farm size significantly influenced the adoption of AMPG. Mass awareness campaigns need to be organized to improve the stakeholders' perception of groundnut quality and the ill-effects of consuming aflatoxin-contaminated products.

No abstract

For conducting advanced analytics initiatives to acquire in-depth data into usage habits, regional access, sales, and promotional success, etc., unique identification of packaged pharmaceuticals will be a fantastic enabler. The main objective of this study is to prevent and reduce the production of erroneous and counterfeit drugs using the enterprise system, which has become a serious threat because it damages the reputation of legitimate drug manufacturers by trying to produce and market placebo medications that are identical to the real thing. Due to federal government procedures and priorities that frequently change over time, the majority of implementation takes time. To achieve compliance with numerous federal regulatory authorities, including drug traceability for patient safety, the pharmaceutical industry must implement a systematic procedure in an ERP environment. The goals would be to guarantee medical drug traceability and provide real-time warnings to supply chain stakeholders and regulatory bodies to maximize the benefit of integrating a drug traceability system into an ERP environment. Additionally, manufacturers are compelled to maintain product costs on the higher side due to a heavy burden of unchecked manufacturing cost spikes. As a result, innovative marketing schemes must be introduced in order to increase the reach to consumers by putting into practice successful strategies.

No abstract